Novartis Institutes for Biomedical Research
Dr. Thomas Troxler is affiliated to Novartis Institutes for BioMedical Research, Novartis Institutes for Biomedical Research. Dr. Thomas Troxler is currently providing services as Professor. Dr. Thomas Troxler has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Thomas Troxler contributions have acclaimed recognition from honourable subject experts around the world. Dr. Thomas Troxler is actively associated with different societies and academies. Dr. Thomas Troxler academic career is decorated with several reputed awards and funding. Dr. Thomas Troxler research interests include Novartis Institutes for BioMedical Research.
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.